8CT-36452-07781
2 vaccinations
1 coded response
25 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 770 / TX
- Registered
- 2021-05-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-05
Registered in v-safe
-
2021-05-05
Dose 1 — Pfizer-BioNTech
-
2021-05-05
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Headache · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-06
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Chills, Headache · Be unable to workAdult check-in
-
2021-05-07
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Rash, not including the immediate area around the injection site · Be unable to workAdult check-in
- 2021-05-08
- 2021-05-09
- 2021-05-10
- 2021-05-11
- 2021-05-12
- 2021-05-19
-
2021-05-25
Dose 2 — Pfizer-BioNTech
- 2021-05-25
- 2021-05-26
- 2021-05-27
- 2021-05-28
- 2021-05-29
- 2021-05-30
- 2021-05-31
- 2021-06-01
- 2021-06-08
- 2021-06-15
- 2021-06-22
- 2021-06-29
- 2021-07-06
- 2021-08-25
- 2021-11-23
-
2022-05-25
Survey response — 12 months, dose 2MedDRA: Headache, Hot flush, Oropharyngeal pain, Pain, Unevaluable event — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Aches, headache, hot flashes, sore each and throat.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-25
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-05-26
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-05 | Pfizer-BioNTech | |
| 2 | 2021-05-25 | Pfizer-BioNTech |
Call center
1 call center case
1 successful
Free text
Release 11 — 12 months, dose 2
Symptoms: Aches, headache, hot flashes, sore each and throat.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
| SD | Hot flush | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Unevaluable event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release